Aggarwal Ajay, Cromwell David, Nossiter Julie, van der Meulen Jan, Walker Kate
Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK; Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK; Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK.
Lancet Oncol. 2025 Apr;26(4):e225-e232. doi: 10.1016/S1470-2045(24)00665-X.
The National Cancer Audit Collaborating Centre (NATCAN) was launched on Oct 1, 2022, and is delivering ten national cancer audits to assess and assure the quality of National Health Service (NHS) cancer care in England and Wales. These audits are a collaboration between clinical leaders, methodological experts, professional organisations, civil society, and policy makers to develop and implement performance measures across all NHS cancer care and inform quality improvement of the care pathway. The aims of NATCAN are to provide transparent and timely feedback to hospitals about their practices and outcomes of cancer care, identify opportunities for improvement of cancer care, and support hospitals to conduct quality-improvement initiatives. The key methods used to achieve these aims were use of routinely collected data that did not necessitate bespoke collection by health-care staff specifically for the audit; public reporting of outcomes of care at hospital and regional levels; assessment of determinants of variation in cancer care to target quality improvement; and a central governance structure to ensure that unsafe care or outlying performance were managed effectively and promptly. This Personal View provides comparisons between NATCAN and other international audit programmes, including how other countries could consider and incorporate components of NATCAN, alongside scope for future development.
国家癌症审计协作中心（NATCAN）于2022年10月1日启动，正在开展十项全国性癌症审计，以评估和确保英格兰和威尔士国民医疗服务体系（NHS）癌症护理的质量。这些审计是临床领导者、方法学专家、专业组织、民间社会和政策制定者之间的合作，旨在制定和实施涵盖所有NHS癌症护理的绩效指标，并为护理路径的质量改进提供信息。NATCAN的目标是向医院提供关于其癌症护理实践和结果的透明且及时的反馈，识别癌症护理改进的机会，并支持医院开展质量改进举措。实现这些目标所采用的关键方法包括：使用常规收集的数据，无需医护人员专门为审计进行定制收集；在医院和地区层面公开报告护理结果；评估癌症护理差异的决定因素以瞄准质量改进；以及建立一个中央治理结构，以确保不安全护理或异常表现得到有效且及时的管理。这篇个人观点文章比较了NATCAN与其他国际审计项目，包括其他国家如何考虑并纳入NATCAN的组成部分，以及未来的发展空间。
